Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide in pediatric functional constipation (6 months to <2 years)
NCT05760313Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Apr 2023
- Primary completion
- Jun 2025
- Modality
- Peptides
- Countries
- 7
01
Overview
A Phase 2 trial of linaclotide in functional constipation (FC), sponsored by AbbVie Inc.. Started Apr 2023; status: completed.
02
Drugs
linaclotide
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on NCT05760313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05760313.